skip to main content
Show Results with: Show Results with:

Genomic Features of Response to Combination Immunotherapy in Lung Cancer

Früh, Martin; Peters, Solange

Cancer cell. Volume 33:Number 5 (2018, May 14th); pp 791-793

Online access

  • Title:
    Genomic Features of Response to Combination Immunotherapy in Lung Cancer
  • Author: Früh, Martin;
    Peters, Solange
  • Found In: Cancer cell. Volume 33:Number 5 (2018, May 14th); pp 791-793
  • Journal Title: Cancer cell
  • Subjects: Dewey: 611.0181
  • Rights: Licensed
  • Abstract: In this issue of Cancer Cell, Hellmann et al. describe in two clinical trials the importance of tumor mutational burden as an independent predictive marker for outcomes with combination nivolumab plus ipilimumab as first-line therapy in metastatic non-small-cell lung cancer and in relapsed small-cell lung cancer. In this issue of Cancer Cell, Hellmann et al. describe in two clinical trials the importance of tumor mutational burden as an independent predictive marker for outcomes with combination nivolumab plus ipilimumab as first-line therapy in metastatic non-small-cell lung cancer and in relapsed small-cell lung cancer.
  • Identifier: System Number: ETOCvdc_100089987722.0x000001; Journal ISSN: 1535-6108; 10.1016/j.ccell.2018.04.005
  • Publication Date: 2018
  • Physical Description: Electronic
  • Shelfmark(s): 3046.464170
  • UIN: ETOCvdc_100089987722.0x000001

Searching Remote Databases, Please Wait